Teva Pharmaceutical Industries ($TEVA) is scheduled to release earnings before Monday's open (Feb 13, 2017). The stock is prone to big moves after reporting earnings and can easily gap up if the numbers are strong. Company Profile & Various Businesses:Here is a complete company profile and description of the various businesses courtesy of my friends at Thomson Reuters Eikon:Teva Pharmaceutical Industries Limited, incorporated on February 13, 1944, is a global pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines.

Source: Forbes February 11, 2017 13:26 UTC